Overview A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The objective of this study is to evaluate the effects of adding Tricor 145 mg to once daily atorvastatin 20 mg on CHD lipid laboratory parameters. Phase: Phase 3 Details Lead Sponsor: AbbottTreatments: AtorvastatinAtorvastatin CalciumEzetimibeFenofibrate